Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed Phase II ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback